MakeMoney24.info

Controversy over a Pfizer anti-smoking drug is fueling debate about whether patients should be told of corporate ties — or whether disclosure would ‘confuse’ them.

Random Posts:

• Dow off 283 on Ford loss, weak home sales
• Save gas: Learn from ‘hypermilers’
• Create a Google Sitemap
• State to hit obese workers with ‘fat fee’
• Crude nears $143, drives stocks lower
• Some Adwords Basics for Beginners
• Crude oil tops $133; Fed’s outlook batters stocks
• Attn: Northeast Ohioans in Career Transition
• The next Internet-sized boom
• Moving up in an up-and-down market

This entry was posted on poniedziałek, czerwiec 30th, 2008 at 10:53 and is filed under Finance. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.